COVID-19 Vaccine

Vaccination Information 

Everyone 6 months and older is eligible and encouraged to get a COVID-19 vaccine. Make sure you stay up to date with primary series doses and boosters. Click the tabs to see CDC's vaccination schedule for your age and situation. 

Vaccination Schedule for Most People

(People who are NOT Moderately or Severely Immunocompromised)

6 months-4 years

Moderna 
  • Total doses: 2
  • Primary series: 2 doses (4-8 weeks between doses)
  • Booster dose: Not currently authorized

Vaccine Fact Sheet: English, Español, አማርኛ, العربية, বাংলা, 한국어Монгол, Pусский中文(简体), ไทย, Tiếng Việt

Pfizer-BioNTech 

  • Total doses: 3
  • Primary series: 3 doses (3-8 weeks between doses 1 and 2; at least 8 weeks between doses 2 and 3) 
  • Booster dose: Not currently authorized

Vaccine Fact Sheet: EnglishEspañolአማርኛالعربيةবাংলা한국어МонголPусский中文(简体)ไทยTiếng Việt

5-11 years

Moderna 
  • Total doses: 3
  • Primary series: 2 doses (4-8 weeks between doses) 
  • Booster dose: 1 updated (bivalent) mRNA booster* 2 or more months after completing the monovalent 2-dose primary series.

*5-year-olds can only receive a Pfizer-BioNTech bivalent booster. Ages 6 and older can receive either a Pfizer-BioNTech or Moderna bivalent booster.

6 Months-5 Years Vaccine Fact Sheet: EnglishEspañolአማርኛالعربيةবাংলা한국어МонголPусский中文(简体)ไทยTiếng Việt

6-11 Years Vaccine Fact Sheet: EnglishEspañolአማርኛالعربيةবাংলা한국어МонголPусский中文(简体)ไทยTiếng Việt

Pfizer-BioNTech 
  • Total doses: 3 or more
  • Primary series: 2 doses (3-8 weeks between doses) 
  • Booster dose: 1 updated (bivalent) mRNA booster* 2 or more months after either:
    • completing the monovalent 2-dose primary series -OR-
    • previously received monovalent booster dose

*5-year-olds can only receive a Pfizer-BioNTech bivalent booster. Ages 6 and older can receive either a Pfizer-BioNTech or Moderna bivalent booster.

Vaccine Fact Sheet: EnglishEspañolአማርኛالعربيةবাংলা한국어МонголPусский中文(简体)ไทยTiếng Việt

12 years-Adult

Moderna
  • Total doses: 3 or more
  • Primary series: 2 doses (4-8 weeks between doses) 
  • Booster dose*: 1 updated (bivalent) booster 2 or more months after either:
  • completing the monovalent 2-dose primary series -OR-
  • previously received monovalent mRNA booster dose  

Vaccine Fact Sheet: EnglishEspañolአማርኛالعربيةবাংলা한국어МонголPусский中文(简体)ไทยTiếng Việt

 Pfizer-BioNTech

  • Total doses: 3 or more
  • Primary series: 2 doses (3-8 weeks between doses) 
  • Booster dose*: 1 updated (bivalent) booster 2 or more months after either:
  • completing the monovalent 2-dose primary series -OR-
  • previously received monovalent mRNA booster dose  

Vaccine Fact Sheet: EnglishEspañolአማርኛالعربيةবাংলা한국어МонголPусский中文(简体)ไทยTiếng Việt

 Novavax

  • Total doses: 3
  • Primary series: 2 doses (3-8 weeks between doses) 
  • Booster dose*: 1 updated (bivalent) booster 2 or more months after completing the 2-dose primary series.  

Vaccine Fact Sheet: EnglishEspañolአማርኛالعربيةবাংলা한국어МонголPусский中文(简体)ไทยTiếng Việt

* People ages 18 years and older who completed primary vaccination using any COVID-19 vaccine may receive 1 monovalent Novavax booster dose at least 6 months after completion of the primary series if they:

  • Have not received any previous booster doses -AND-
  • Are unable to receive an mRNA vaccine (i.e., mRNA vaccine contraindicated or not available) -OR-
  • Are unwilling to receive an mRNA vaccine and would otherwise not receive a booster dose.

J&J (Janssen) Recipients

Johnson and Johnson (Janssen)
  • Total doses: 2 or more
  • Primary series: 1 dose 
  • Booster dose*: 1 updated (bivalent) booster 2 or more months after either:
  • completing the 1-dose primary series -OR-
  • previously received monovalent booster dose(s) 

Vaccine Fact Sheet: EnglishEspañolአማርኛالعربيةবাংলা한국어МонголPусский中文(简体)ไทยTiếng Việt

* People ages 18 years and older who completed primary vaccination using any COVID-19 vaccine may receive 1 monovalent Novavax booster dose at least 6 months after completion of the primary series if they:

  • Have not received any previous booster doses -AND-
  • Are unable to receive an mRNA vaccine (i.e., mRNA vaccine contraindicated or not available) -OR-
  • Are unwilling to receive an mRNA vaccine and would otherwise not receive a booster dose.

 

The Food and Drug Administration (FDA) maintains a list of all approved and authorized COVID-19 vaccines. Talk to your healthcare provider for additional guidance. The COVID-19 Vaccination Schedule for People Who are Moderately or Severely Immunocompromised is provided in the table below. The CDC maintains a current COVID-19 vaccine schedule for most people and people who are moderately or severely immunocompromised. 

Scroll below to view the vaccine schedule for people who are moderately or severely immunocompromised.


Vaccination Schedule for People who are Moderately or Severely Immunocompromised

This section is for people who are moderately or severely immunocompromised. The immune response following COVID-19 vaccination may differ in people who are moderately or severely immunocompromised at the time of vaccination. CDC has specific guidance for this population as described below.

6 months-4 years

Moderna
  • Total doses: 3
  • Primary series: 3 doses (4 weeks between doses 1 and 2; at least 4 weeks between doses 2 and 3)
  • Booster dose: Not currently authorized

Vaccine Fact Sheet: EnglishEspañolአማርኛالعربيةবাংলা한국어МонголPусский中文(简体)ไทยTiếng Việt

Pfizer-BioNTech 
  • Total doses: 3
  • Primary series: 3 doses (3 weeks between doses 1 and 2; at least 8 weeks between doses 2 and 3) 
  • Booster dose: Not currently authorized

Vaccine Fact Sheet: EnglishEspañolአማርኛالعربيةবাংলা한국어МонголPусский中文(简体)ไทยTiếng Vit

5-11 years

Moderna
  • Total doses: 4
  • Primary series: 3 doses (4 weeks between doses 1 and 2; at least 4 weeks between doses 2 and 3)
  • Booster dose: 1 updated (bivalent) mRNA booster* 2 or more months after completing the monovalent 3-dose primary series.

*5-year-olds can only receive a Pfizer-BioNTech bivalent booster. Ages 6 and older can receive either a Pfizer-BioNTech or Moderna bivalent booster.

6 Months-5 Years Vaccine Fact Sheet: EnglishEspañolአማርኛالعربيةবাংলা한국어МонголPусский中文(简体)ไทยTiếng Việt

6-11 Years Vaccine Fact Sheet: EnglishEspañolአማርኛالعربيةবাংলা한국어МонголPусский中文(简体)ไทยTiếng Việt

Pfizer-BioNTech
  • Total doses: 4 or more
  • Primary series: 3 doses (3 weeks between doses 1 and 2; at least 8 weeks between doses 2 and 3) 
  • Booster dose: 1 updated (bivalent) mRNA booster* 2 or more months after either:
    • completing the monovalent 3-dose primary series -OR-
    • previously received monovalent booster dose

*5-year-olds can only receive a Pfizer-BioNTech bivalent booster. Ages 6 and older can receive either a Pfizer-BioNTech or Moderna bivalent booster.

Vaccine Fact SheetEnglishEspañolአማርኛالعربيةবাংলা한국어МонголPусский中文(简体)ไทยTiếng Việt

12 years-Adult

Moderna
  • Total doses: 4 or more
  • Primary series: 3 doses (4 weeks between doses 1 and 2; at least 4 weeks between doses 2 and 3)
  • Booster dose*: 1 updated (bivalent) booster 2 or more months after either:
    • completing the monovalent 3-dose primary series -OR-
    • previously received monovalent mRNA booster dose(s)  

Vaccine Fact Sheet: EnglishEspañolአማርኛالعربيةবাংলা한국어МонголPусский中文(简体)ไทยTiếng Việt

Pfizer-BioNTech

  • Total doses: 4 or more
  • Primary series: 3 doses (3 weeks between doses 1 and 2; at least 4 weeks between doses 2 and 3) 
  • Booster dose*: 1 updated (bivalent) booster 2 or more months after either:
  • completing the monovalent 3-dose primary series -OR-
  • previously received monovalent mRNA booster dose(s)  

Vaccine Fact Sheet: EnglishEspañolአማርኛالعربيةবাংলা한국어МонголPусский中文(简体)ไทยTiếng Việt

Novavax

  • Total doses: 3
  • Primary series: 2 doses (3 weeks between doses) 
  • Booster dose*: 1 updated (bivalent) mRNA booster 2 or more months after completing the 2-dose primary series.  

Vaccine Fact Sheet: EnglishEspañolአማርኛالعربيةবাংলা한국어МонголPусский中文(简体)ไทยTiếng Việt

* People ages 18 years and older who completed primary vaccination using any COVID-19 vaccine may receive 1 monovalent Novavax booster dose at least 6 months after completion of the primary series if they:

  • Have not received any previous booster doses -AND-
  • Are unable to receive an mRNA vaccine (i.e., mRNA vaccine contraindicated or not available) -OR-
  • Are unwilling to receive an mRNA vaccine and would otherwise not receive a booster dose.

J&J (Janssen) Recipients

Johnson and Johnson (Janssen)
  • Total doses: 3 or more
  • Primary series: 1 dose of Johnson & Johnson
  • Additional dose: 1 dose of an mRNA vaccine at least 4 weeks after dose 1 
  • Booster dose*: 1 updated (bivalent) booster 2 or more months after either:
  • completing the primary series and additional dose -OR-
  • previously received monovalent booster dose(s) 

Vaccine Fact Sheet: EnglishEspañolአማርኛالعربيةবাংলা한국어МонголPусский中文(简体)ไทยTiếng Việt

* People ages 18 years and older who completed primary vaccination using any COVID-19 vaccine may receive 1 monovalent Novavax booster dose at least 6 months after completion of the primary series if they:

  • Have not received any previous booster doses -AND-
  • Are unable to receive an mRNA vaccine (i.e., mRNA vaccine contraindicated or not available) -OR-
  • Are unwilling to receive an mRNA vaccine and would otherwise not receive a booster dose.

 

The Food and Drug Administration (FDA) maintains a list of all approved and authorized COVID-19 vaccines. Talk to your healthcare provider for additional guidance. The COVID-19 Vaccination Schedule for Most People (people who are NOT moderately or severely immunocompromised) is provided in the table above. The CDC maintains a current COVID-19 vaccination schedule for most people and people who are moderately or severely immunocompromised. 

Additional Resources (last updated 6/24/2022)